Wright Investors Service Inc. Boosts Position in Danaher Co. (DHR)
Wright Investors Service Inc. raised its stake in shares of Danaher Co. (NYSE:DHR) by 9.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,840 shares of the conglomerate’s stock after buying an additional 1,195 shares during the period. Wright Investors Service Inc.’s holdings in Danaher were worth $1,184,000 as of its most recent filing with the SEC.
Several other large investors have also added to or reduced their stakes in DHR. Aperio Group LLC raised its stake in Danaher by 41.7% in the third quarter. Aperio Group LLC now owns 452,125 shares of the conglomerate’s stock valued at $35,442,000 after buying an additional 132,949 shares during the last quarter. Macguire Cheswick & Tuttle Investment Counsel LLC raised its stake in Danaher by 1.7% in the third quarter. Macguire Cheswick & Tuttle Investment Counsel LLC now owns 161,450 shares of the conglomerate’s stock valued at $12,656,000 after buying an additional 2,690 shares during the last quarter. Decatur Capital Management Inc. raised its stake in Danaher by 2.8% in the third quarter. Decatur Capital Management Inc. now owns 155,550 shares of the conglomerate’s stock valued at $12,194,000 after buying an additional 4,250 shares during the last quarter. Aviva PLC raised its stake in Danaher by 7.2% in the fourth quarter. Aviva PLC now owns 384,738 shares of the conglomerate’s stock valued at $29,971,000 after buying an additional 25,897 shares during the last quarter. Finally, Quest Investment Management Inc. OR raised its stake in Danaher by 16.9% in the fourth quarter. Quest Investment Management Inc. OR now owns 214,507 shares of the conglomerate’s stock valued at $16,697,000 after buying an additional 31,038 shares during the last quarter. 76.14% of the stock is owned by hedge funds and other institutional investors.
Danaher Co. (NYSE:DHR) opened at 84.51 on Friday. Danaher Co. has a 1-year low of $75.71 and a 1-year high of $102.79. The company has a market capitalization of $58.66 billion, a P/E ratio of 25.76 and a beta of 1.00. The firm has a 50-day moving average price of $83.86 and a 200 day moving average price of $82.53.
Danaher (NYSE:DHR) last posted its quarterly earnings data on Thursday, April 20th. The conglomerate reported $0.85 EPS for the quarter, beating the Zacks’ consensus estimate of $0.84 by $0.01. The business had revenue of $4.21 billion during the quarter, compared to analysts’ expectations of $4.17 billion. Danaher had a return on equity of 12.38% and a net margin of 12.84%. The business’s revenue was up 7.2% compared to the same quarter last year. During the same period in the previous year, the business earned $1.08 earnings per share. On average, equities analysts predict that Danaher Co. will post $3.92 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 28th. Stockholders of record on Friday, June 30th will be given a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date of this dividend is Wednesday, June 28th. Danaher’s dividend payout ratio (DPR) is presently 13.66%.
Several equities research analysts have recently commented on DHR shares. Credit Suisse Group AG raised shares of Danaher from a “neutral” rating to an “outperform” rating and upped their price target for the company from $80.00 to $93.00 in a research report on Wednesday, February 1st. Citigroup Inc raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $98.00 price target for the company in a research report on Friday, February 24th. Vetr raised shares of Danaher from a “hold” rating to a “buy” rating and set a $95.50 price target for the company in a research report on Monday, February 27th. BTIG Research reaffirmed a “buy” rating and set a $92.00 price target on shares of Danaher in a research report on Sunday, April 23rd. Finally, Jefferies Group LLC upped their price target on shares of Danaher from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Wednesday, February 1st. Three investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $92.29.
In other news, SVP Angela S. Lalor sold 10,815 shares of the business’s stock in a transaction that occurred on Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total value of $910,190.40. Following the completion of the sale, the senior vice president now directly owns 39,020 shares in the company, valued at $3,283,923.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Thomas Patrick Joyce, Jr. sold 54,006 shares of the business’s stock in a transaction that occurred on Friday, April 21st. The shares were sold at an average price of $82.52, for a total value of $4,456,575.12. Following the completion of the sale, the insider now owns 142,157 shares of the company’s stock, valued at $11,730,795.64. The disclosure for this sale can be found here. Insiders sold 83,248 shares of company stock valued at $6,900,377 over the last 90 days. Company insiders own 12.60% of the company’s stock.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Stock Ratings for Danaher Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Co. and related stocks with our FREE daily email newsletter.